Harpoon

Business

Merck in talks to acquire Harpoon Therapeutics for around $700M – Bloomberg (NYSE:MRK)

Merck (NYSE:MRK) is reportedly in advanced talks to buy immuno-oncology company Harpoon Therapeutics (NASDAQ:HARP) for around $700M. Citing people familiar…

Read More »
Back to top button